• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells.HIV-1 利用 CXCR4 趋化因子受体感染多能造血干细胞和祖细胞。
Cell Host Microbe. 2011 Mar 17;9(3):223-234. doi: 10.1016/j.chom.2011.02.005.
2
CD4 is expressed on a heterogeneous subset of hematopoietic progenitors, which persistently harbor CXCR4 and CCR5-tropic HIV proviral genomes in vivo.CD4在造血祖细胞的一个异质性亚群上表达,这些造血祖细胞在体内持续携带嗜CXCR4和CCR5的HIV前病毒基因组。
PLoS Pathog. 2017 Jul 21;13(7):e1006509. doi: 10.1371/journal.ppat.1006509. eCollection 2017 Jul.
3
Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice.尽管酪氨酸激酶抑制剂伊马替尼在体外抑制造血祖细胞生长,但它并不损害人CD133+细胞植入NOD/SCIDβ2mNull小鼠体内。
Stem Cells. 2006 Jul;24(7):1814-21. doi: 10.1634/stemcells.2005-0290. Epub 2006 Apr 13.
4
Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.人类免疫缺陷病毒(HIV)受体/共受体在分化的造血前体细胞中的谱系特异性表达:与对T嗜性和M嗜性HIV的易感性及趋化因子介导的HIV抗性的相关性
Blood. 1999 Sep 1;94(5):1590-600.
5
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.HIV-1 感染多能祖细胞,导致细胞死亡并建立潜伏的细胞储库。
Nat Med. 2010 Apr;16(4):446-51. doi: 10.1038/nm.2109. Epub 2010 Mar 7.
6
The frequency of multipotent CD133(+)CD45RA(-)CD34(+) hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources.与成体干细胞来源相比,胎儿肝脏中多能性CD133(+)CD45RA(-)CD34(+)造血干细胞的频率并未增加。
Exp Hematol. 2016 Jun;44(6):502-7. doi: 10.1016/j.exphem.2016.02.011. Epub 2016 Mar 22.
7
RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.基于RNA的抗HIV-1基因治疗构建体在SCID-hu小鼠模型中的研究
Mol Ther. 2002 Dec;6(6):770-82. doi: 10.1006/mthe.2002.0800.
8
Human immunodeficiency virus infection of human placental cord blood CD34+AC133+ stem cells and their progeny.人类免疫缺陷病毒对人胎盘脐带血CD34+AC133+干细胞及其后代的感染
AIDS Res Hum Retroviruses. 1999 Nov 20;15(17):1545-52. doi: 10.1089/088922299309838.
9
HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo.HIV-1 体外和体内感染长期造血前体细胞。
Cells. 2022 Sep 23;11(19):2968. doi: 10.3390/cells11192968.
10
CD133+ hematopoietic progenitor cells harbor HIV genomes in a subset of optimally treated people with long-term viral suppression.在经过最佳治疗且长期病毒抑制的人群中,一部分 CD133+ 造血祖细胞中携带 HIV 基因组。
J Infect Dis. 2013 Jun 15;207(12):1807-16. doi: 10.1093/infdis/jit118. Epub 2013 Apr 3.

引用本文的文献

1
CD34 serves as an intrinsic innate immune guardrail protecting stem cells from replicating retroviruses.CD34作为一种内在的先天性免疫屏障,保护干细胞免受逆转录病毒的复制。
bioRxiv. 2025 Mar 17:2025.03.15.643450. doi: 10.1101/2025.03.15.643450.
2
ISG15-LFA1 interactions in latent HIV clearance: mechanistic implications in designing antiviral therapies.ISG15与LFA1相互作用在潜伏性HIV清除中的作用:对抗病毒疗法设计的机制启示
Front Cell Dev Biol. 2024 Dec 24;12:1497964. doi: 10.3389/fcell.2024.1497964. eCollection 2024.
3
A New Chimeric Antibody against the HIV-1 Fusion Inhibitory Peptide MT-C34 with a High Affinity and Fc-Mediated Cellular Cytotoxicity.一种针对HIV-1融合抑制肽MT-C34的新型嵌合抗体,具有高亲和力和Fc介导的细胞毒性。
Biology (Basel). 2024 Aug 29;13(9):675. doi: 10.3390/biology13090675.
4
Recognition of HIV-1-infected fibrocytes lacking Nef-mediated HLA-B downregulation by HIV-1-specific T cells.HIV-1 特异性 T 细胞识别缺乏 Nef 介导 HLA-B 下调的 HIV-1 感染成纤维细胞。
J Virol. 2024 Jul 23;98(7):e0079124. doi: 10.1128/jvi.00791-24. Epub 2024 Jun 28.
5
Mechanisms and Cardiorenal Complications of Chronic Anemia in People with HIV.HIV感染者慢性贫血的机制及心肾并发症
Viruses. 2024 Mar 30;16(4):542. doi: 10.3390/v16040542.
6
HIV-1 proviral DNA in purified peripheral blood CD34 stem and progenitor cells in individuals with long-term HAART; paving the way to HIV gene therapy.长期接受高效抗逆转录病毒治疗(HAART)的个体中,纯化外周血CD34干细胞和祖细胞中的HIV-1前病毒DNA;为HIV基因治疗铺平道路。
Heliyon. 2024 Feb 17;10(4):e26613. doi: 10.1016/j.heliyon.2024.e26613. eCollection 2024 Feb 29.
7
Characteristics and mechanisms of latency-reversing agents in the activation of the human immunodeficiency virus 1 reservoir.潜伏逆转剂激活人类免疫缺陷病毒 1 储存库的特征和机制。
Arch Virol. 2023 Nov 29;168(12):301. doi: 10.1007/s00705-023-05931-2.
8
Consequences of HIV infection in the bone marrow niche.HIV 感染对骨髓龛的影响。
Front Immunol. 2023 Jul 11;14:1163012. doi: 10.3389/fimmu.2023.1163012. eCollection 2023.
9
Bat pluripotent stem cells reveal unusual entanglement between host and viruses.蝙蝠多能干细胞揭示了宿主与病毒之间不寻常的纠缠关系。
Cell. 2023 Mar 2;186(5):957-974.e28. doi: 10.1016/j.cell.2023.01.011. Epub 2023 Feb 21.
10
HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo.HIV-1 体外和体内感染长期造血前体细胞。
Cells. 2022 Sep 23;11(19):2968. doi: 10.3390/cells11192968.

本文引用的文献

1
HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.HIV-1 感染多能祖细胞,导致细胞死亡并建立潜伏的细胞储库。
Nat Med. 2010 Apr;16(4):446-51. doi: 10.1038/nm.2109. Epub 2010 Mar 7.
2
Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study.多中心艾滋病队列研究中男性群体中嗜CXCR4的HIV-1的出现与持续存在
J Infect Dis. 2008 Oct 15;198(8):1104-12. doi: 10.1086/591623.
3
Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription.在逆转录完成之前,体外X4嗜性1型人类免疫缺陷病毒感染对外周记忆CD4 + T细胞的优先细胞溶解作用。
J Virol. 2008 Sep;82(18):9154-63. doi: 10.1128/JVI.00773-08. Epub 2008 Jul 2.
4
The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.HIV嗜性对CD4细胞计数下降、临床进展以及后续对首个抗逆转录病毒治疗方案反应的影响。
Clin Infect Dis. 2008 May 15;46(10):1617-23. doi: 10.1086/587660.
5
HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy.HIV-1 共受体使用情况和 CXCR4 特异性病毒载量可预测联合抗逆转录病毒治疗期间的临床疾病进展。
AIDS. 2008 Feb 19;22(4):469-79. doi: 10.1097/QAD.0b013e3282f4196c.
6
Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation.通过NOD/SCID移植检测发现,血管生成素样蛋白5和胰岛素样生长因子结合蛋白2可刺激人脐带血造血干细胞的体外扩增。
Blood. 2008 Apr 1;111(7):3415-23. doi: 10.1182/blood-2007-11-122119. Epub 2008 Jan 17.
7
Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa.HIV-1 C亚型对造血祖细胞的感染及其与非洲南部贫血的关联。
Blood. 2007 Nov 1;110(9):3143-9. doi: 10.1182/blood-2007-04-086314. Epub 2007 Aug 10.
8
Baseline HIV type 1 coreceptor tropism predicts disease progression.基线HIV-1型共受体嗜性可预测疾病进展。
Clin Infect Dis. 2007 Sep 1;45(5):643-9. doi: 10.1086/520650. Epub 2007 Jul 20.
9
Primitive hematopoietic cells resist HIV-1 infection via p21.原始造血细胞通过p21抵抗HIV-1感染。
J Clin Invest. 2007 Feb;117(2):473-81. doi: 10.1172/JCI28971.
10
Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved?利用CCR5的HIV-1的选择性传播:“守门人”问题解决了吗?
Nat Rev Microbiol. 2006 Apr;4(4):312-7. doi: 10.1038/nrmicro1387.

HIV-1 利用 CXCR4 趋化因子受体感染多能造血干细胞和祖细胞。

HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells.

机构信息

Graduate Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI 48109, USA; Medical Scientist Training Program, University of Michigan, Ann Arbor, MI 48109, USA.

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA; Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, USA.

出版信息

Cell Host Microbe. 2011 Mar 17;9(3):223-234. doi: 10.1016/j.chom.2011.02.005.

DOI:10.1016/j.chom.2011.02.005
PMID:21402361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3102232/
Abstract

HIV infection is characterized by gradual immune system collapse and hematopoietic dysfunction. We recently showed that HIV enters multipotent hematopoietic progenitor cells and establishes both active cytotoxic and latent infections that can be reactivated by myeloid differentiation. However, whether these multipotent progenitors include long-lived hematopoietic stem cells (HSCs) that could establish viral reservoirs for the life of the infected person remains unknown. Here we provide direct evidence that HIV targets long-lived HSCs and show that infected HSCs yield stable, multilineage engraftment in a xenograft model. Furthermore, we establish that the capacity to use the chemokine receptor CXCR4 for entry determines whether a virus will enter multipotent versus differentiated progenitor cells. Because HSCs live for the life span of the infected person and are crucial for hematopoietic health, these data may explain the poor prognosis associated with CXCR4-tropic HIV infection and suggest HSCs as long-lived cellular reservoirs of latent HIV.

摘要

HIV 感染的特征是免疫系统逐渐崩溃和造血功能障碍。我们最近表明,HIV 进入多能造血祖细胞,并建立既能进行活性细胞毒性感染又能建立潜伏感染的状态,这两种感染均可被髓系分化所激活。然而,这些多能祖细胞是否包括可建立感染个体终生病毒储存库的长寿造血干细胞(HSCs)仍不清楚。在这里,我们提供了 HIV 靶向长寿 HSCs 的直接证据,并表明感染的 HSCs 在异种移植模型中产生稳定的多谱系嵌合体。此外,我们确定了利用趋化因子受体 CXCR4 进行进入的能力决定了病毒将进入多能性还是分化祖细胞。由于 HSCs 的寿命与感染个体的寿命相同,并且对造血健康至关重要,这些数据可能解释了与 CXCR4 嗜性 HIV 感染相关的不良预后,并提示 HSCs 是潜伏 HIV 的长期细胞储存库。